1. Home
  2. FBIO vs LSE Comparison

FBIO vs LSE Comparison

Compare FBIO & LSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIO
  • LSE
  • Stock Information
  • Founded
  • FBIO 2006
  • LSE 2007
  • Country
  • FBIO United States
  • LSE China
  • Employees
  • FBIO N/A
  • LSE N/A
  • Industry
  • FBIO Biotechnology: Pharmaceutical Preparations
  • LSE Metal Fabrications
  • Sector
  • FBIO Health Care
  • LSE Industrials
  • Exchange
  • FBIO Nasdaq
  • LSE Nasdaq
  • Market Cap
  • FBIO 88.7M
  • LSE 87.7M
  • IPO Year
  • FBIO N/A
  • LSE 2024
  • Fundamental
  • Price
  • FBIO $2.75
  • LSE $5.49
  • Analyst Decision
  • FBIO Strong Buy
  • LSE
  • Analyst Count
  • FBIO 2
  • LSE 0
  • Target Price
  • FBIO $16.50
  • LSE N/A
  • AVG Volume (30 Days)
  • FBIO 341.4K
  • LSE 2.8K
  • Earning Date
  • FBIO 11-14-2025
  • LSE 09-30-2025
  • Dividend Yield
  • FBIO N/A
  • LSE N/A
  • EPS Growth
  • FBIO N/A
  • LSE N/A
  • EPS
  • FBIO N/A
  • LSE 0.14
  • Revenue
  • FBIO $62,303,000.00
  • LSE $57,385,142.00
  • Revenue This Year
  • FBIO $31.85
  • LSE N/A
  • Revenue Next Year
  • FBIO $44.43
  • LSE N/A
  • P/E Ratio
  • FBIO N/A
  • LSE $38.87
  • Revenue Growth
  • FBIO N/A
  • LSE N/A
  • 52 Week Low
  • FBIO $1.33
  • LSE $3.76
  • 52 Week High
  • FBIO $4.20
  • LSE $14.99
  • Technical
  • Relative Strength Index (RSI)
  • FBIO 55.02
  • LSE 56.36
  • Support Level
  • FBIO $2.40
  • LSE $5.15
  • Resistance Level
  • FBIO $2.76
  • LSE $5.39
  • Average True Range (ATR)
  • FBIO 0.16
  • LSE 0.07
  • MACD
  • FBIO 0.03
  • LSE 0.01
  • Stochastic Oscillator
  • FBIO 94.59
  • LSE 89.34

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

About LSE Leishen Energy Holding Co. Ltd. Ordinary Shares

Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment; oil and gas engineering technical services; new energy production and operation; and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment which supplies various equipments, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.

Share on Social Networks: